MedPath

Patients With Acute Renal Failure During Severe COVID-19

Conditions
Renal Failure Chronic
Registration Number
NCT05077163
Lead Sponsor
University Hospital, Strasbourg, France
Brief Summary

The occurrence of renal failure during severe forms of COVID-19 is common (20-35% of patients treated in intensive care) and associated with an unfavorable short-term prognosis, but the medium-term renal outcome is not is not known.

The aim of the study is to establish the frequency of chronic kidney failure after AKI KDIGO 2 and 3 occurring during severe COVID-19 in intensive care.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Retrospective study of renal development in patients with acute renal failure during severe COVID-19Files analysed retrospectively from February 01, 2020 to July 31, 2020 will be examined]
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Service de Néphrologie et Transplantation - Hôpitaux Universitaires de Strasbourg

🇫🇷

Strasbourg, France

© Copyright 2025. All Rights Reserved by MedPath